Literature DB >> 30109346

Synthesis of next generation dual-responsive cross-linked nanoparticles and their application to anti-cancer drug delivery.

Christina Schwarzenböck1, Peter J Nelson, Ralf Huss, Bernhard Rieger.   

Abstract

Rare earth metal-mediated group transfer polymerisation enables the synthesis of previously inaccessible block copolymers of 2-vinylpyridine, diethyl vinylphosphonate and the new diallyl vinylphosphonate monomer. This precision polymerisation and the selective cross-linking of allyl side groups via thiol-ene click chemistry leads to the formation of well-defined dual-responsive nanoparticles. We demonstrate that these next generation nanocarriers are pH- and temperature-responsive and are capable of efficiently delivering doxorubicin into the nucleus of cancer cells. High anti-cancer activity could be demonstrated via cytotoxicity tests on breast cancer (MCF-7) and cervical cancer (HeLa) cells. These results validate this modular synthesis route as an ideal platform for the development of sophisticated nanocarriers for future drug delivery applications.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30109346     DOI: 10.1039/c8nr04760j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  3 in total

1.  Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy.

Authors:  Yayu Wang; Jie Yao; Lizhao Cai; Tong Liu; Xiaogang Wang; Ye Zhang; Zhiying Zhou; Tingwei Li; Minyi Liu; Renfa Lai; Xiangning Liu
Journal:  Int J Nanomedicine       Date:  2020-10-15

2.  Allyl group-containing polyvinylphosphonates as a flexible platform for the selective introduction of functional groups via polymer-analogous transformations.

Authors:  Kerstin Halama; Andreas Schaffer; Bernhard Rieger
Journal:  RSC Adv       Date:  2021-11-30       Impact factor: 3.361

3.  Synthesis, characterisation and functionalisation of BAB-type dual-responsive nanocarriers for targeted drug delivery: evolution of nanoparticles based on 2-vinylpyridine and diethyl vinylphosphonate.

Authors:  Andreas Saurwein; Andreas Schaffer; Christina Wieser; Bernhard Rieger
Journal:  RSC Adv       Date:  2021-01-05       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.